guidance

Himax Technologies, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results; Provides First Quarter 2025 GuidanceHimax Technologies, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results; Provides First Quarter 2025 Guidance

Himax Technologies, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results; Provides First Quarter 2025 Guidance

Q4 2024 Revenues, Gross Margin and EPS All Surpassed Guidance Range Issued on November 7, 2024Company Q1 2025 Guidance: Revenues…

6 days ago
Press Release: Q4 sales growth of 10.3%, 2024 business EPS guidance exceeded, and strong business EPS rebound expected in 2025Press Release: Q4 sales growth of 10.3%, 2024 business EPS guidance exceeded, and strong business EPS rebound expected in 2025

Press Release: Q4 sales growth of 10.3%, 2024 business EPS guidance exceeded, and strong business EPS rebound expected in 2025

Sanofi: Q4 sales growth of 10.3%, 2024 business EPS guidance exceeded, and strong business EPS rebound expected in 2025 Paris,…

3 weeks ago
Riber: 2024 business growth in line with guidanceRiber: 2024 business growth in line with guidance

Riber: 2024 business growth in line with guidance

2024 business growth in line with guidance  Revenues up +5% to €41.2mOrder book at end-2024: €21.7m Bezons (France), January 29,…

3 weeks ago
NEXGEL Issues Letter to Shareholders and Provides Guidance for 2024 and 2025NEXGEL Issues Letter to Shareholders and Provides Guidance for 2024 and 2025

NEXGEL Issues Letter to Shareholders and Provides Guidance for 2024 and 2025

Management expects 2024 fourth quarter revenue of approximately $3.0 million and full year 2024 of approximately $8.6 million, representing growth…

4 weeks ago
BrightSpring Health Services, Inc. Enters into Definitive Agreement to Divest Community Living Business to Sevita; Reports Preliminary 2024 Financial Results and Provides 2025 Guidance Excluding Community LivingBrightSpring Health Services, Inc. Enters into Definitive Agreement to Divest Community Living Business to Sevita; Reports Preliminary 2024 Financial Results and Provides 2025 Guidance Excluding Community Living

BrightSpring Health Services, Inc. Enters into Definitive Agreement to Divest Community Living Business to Sevita; Reports Preliminary 2024 Financial Results and Provides 2025 Guidance Excluding Community Living

Streamlined organization and Provider Services segment to optimize resource allocationProvider Services focus on Home Health/Hospice, Personal Care, Rehabilitation Services, and…

4 weeks ago
Telix Exceeds FY24 Guidance with US$142M Q4 RevenueTelix Exceeds FY24 Guidance with US$142M Q4 Revenue

Telix Exceeds FY24 Guidance with US$142M Q4 Revenue

January 13, 2025 02:08 ET  | Source: Telix Pharmaceuticals Limited MELBOURNE, Australia and INDIANAPOLIS, Jan. 13, 2025 (GLOBE NEWSWIRE) --…

1 month ago
LeaseCrunch Announces Webinar to Offer Guidance for Navigating Year-End Lease ChallengesLeaseCrunch Announces Webinar to Offer Guidance for Navigating Year-End Lease Challenges

LeaseCrunch Announces Webinar to Offer Guidance for Navigating Year-End Lease Challenges

MILWAUKEE, Dec. 10, 2024 (GLOBE NEWSWIRE) -- LeaseCrunch LLC, a leading lease accounting software company, announces the upcoming webinar “2025…

2 months ago
Theriva Biologics Announces U.S. FDA Guidance on Design of Phase 3 Study of VCN-01 for the Treatment of Metastatic Pancreatic CancerTheriva Biologics Announces U.S. FDA Guidance on Design of Phase 3 Study of VCN-01 for the Treatment of Metastatic Pancreatic Cancer

Theriva Biologics Announces U.S. FDA Guidance on Design of Phase 3 Study of VCN-01 for the Treatment of Metastatic Pancreatic Cancer

December 05, 2024 08:00 ET | Source: Theriva Biologics, Inc. ROCKVILLE, Md., Dec. 05, 2024 (GLOBE NEWSWIRE) -- Theriva™ Biologics…

3 months ago
Novartis upgrades mid-term guidance and highlights deep pipeline in core therapeutic areas to drive long-term growthNovartis upgrades mid-term guidance and highlights deep pipeline in core therapeutic areas to drive long-term growth

Novartis upgrades mid-term guidance and highlights deep pipeline in core therapeutic areas to drive long-term growth

Ad hoc announcement pursuant to Art. 53 LR Mid-term sales guidance upgraded to +6% CAGR 2023-2028 and +5% 2024-2029Strong momentum…

3 months ago
RadNet Reports Third Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA and Revises Upwards 2024 Financial Guidance RangesRadNet Reports Third Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA and Revises Upwards 2024 Financial Guidance Ranges

RadNet Reports Third Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA and Revises Upwards 2024 Financial Guidance Ranges

Total Company Revenue increased 14.7% to $461.1 million in the third quarter of 2024 from $402.0 million in the third…

3 months ago